Evidence-Based Practices for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder

Publisher: Washington, DC: Mathematica Policy Research
Apr 09, 2012
Jonathan D. Brown, Allison Barrett, Henry Ireys, Emily Caffery, and Kerianne Hourihan
As part of a project for the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Disability, Aging, and Long-Term Care Policy, Mathematica produced report examining the use of evidence-based medications, psychosocial services, and physical health care practices for Medicaid beneficiaries with schizophrenia and bipolar disorder. Using 2007 Medicaid Analytic eXtract (MAX) data from 22 states, the study found that, overall, only 5 percent of beneficiaries received all of the following: a continuous supply of evidence-based medications, medication level monitoring and screenings for medication side effects, and psychosocial services.